#eastafnet4 search results

#DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

Phiso_de's tweet image. #DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR 🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure #CASTLEAF #Afib #EASTAFNET4#CNC2022 @HMethodistCV @LadorAdi

AayushShahMD's tweet image. ✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR

🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure  #CASTLEAF

#Afib     #EASTAFNET4#CNC2022            @HMethodistCV     @LadorAdi

📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet 👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing? ✒️ @TJaredBunch et al 🔗doi.org/10.1111/jce.16…

JCardioEP's tweet image. 📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet

👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing?

✒️ @TJaredBunch et al

🔗doi.org/10.1111/jce.16…

#EHRA2022 🔥Late-Breaking Interview on a meta-analysis of EAST-AFNET 4 with @DrJasonAndrade 🫀Early rhythm control beneficial for #AF patients ⬇️ in cardiovascular outcomes Discover the key findings 🎥 ow.ly/Nvql50IIFal #EASTAFNET4 #AtrialFibrillation #EarlyRhythmControl


Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu New guidelines per EAST-AFNET4: ✔️Statistically lower risk of stroke and mortality with early rhythm control ✔️Lower risk for hospitalization due to HF and ACS #Afib #EASTAFNET4 #CNC2022

AayushShahMD's tweet image. Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu

New guidelines per EAST-AFNET4: 
✔️Statistically lower risk of stroke and mortality with early rhythm control
✔️Lower risk for hospitalization due to HF and ACS

#Afib #EASTAFNET4 #CNC2022

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

ehj_ed's tweet image. Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

#EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

MDEdgeTweets's tweet image. #EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies More:bit.ly/34OfrUk @ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

CVR_TomaszGuzik's tweet image. Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies
More:bit.ly/34OfrUk
@ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

無症状AFに対するリズムコントロールの意義は? 少しずつエビデンス出てきましたね!嬉しいです。 #ESCCongress #EASTAFNET4 #U40HF

Rhythm control for all? Prespecified subanalysis of the EAST-AFNET 4 trial shows that early, systematic rhythm control was not different between asymptomatic and symptomatic patients academic.oup.com/eurheartj/arti… #EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes

ESC_Journals's tweet image. Rhythm control for all? Prespecified subanalysis of the EAST-AFNET 4 trial shows that early, systematic rhythm control was not different between asymptomatic and symptomatic patients academic.oup.com/eurheartj/arti… 

 #EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes


A full day learning in #ESCCongress2020 with #EMPERORReduced #EASTAFNET4 #EXPLORERHCM and all the amazing programme of congress day one! Thank u all #ESCCongress2020 team!


En un análisis post-hoc del #EASTAFNET4 se observó disminución del riesgo de infarto cerebral 🧠 (primer evento / recurrencia). 🧵3/4


En el estudio #EASTAFNET4 se demostró que control de ritmo💃🏻 en pacientes con FA de diagnóstico reciente disminuye mortalidad 💀asociada a eventos cardiovasculares🫀. 🧵2/4


The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

KnowYourPulse's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

#EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

MDedgeCardio's tweet image. #EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

#EASTAFNET4⚡️❤️⚡️ rhythm🆚rate in #AFib N= 2789, EARLY rhythm control⤵️ 36% #flecainide, 20% #amiodarone,17% #dronedarone, 8% #ablation ⚡️ ❣️🙌🏼 90% on oral #anticoagulant for med. #Chads2Vasc of 3.4 ⬇️ #CV💀& #stroke 3.9🆚5%/yr. ⬆️ #bradycardia #ADR in 💊⚡️ NSR @ 2yrs. 80🆚 60%

In this trial comparing early rhythm control with usual care in patients with early atrial fibrillation and cardiovascular conditions, early rhythm control reduced the rate of death from cardiovascular causes and cardiovascular complications. #ESCCongress



The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

AtrialFibUK's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

Welche #Vorhofflimmern Patienten sollten bevorzugt eine rhythmuserhaltende Therapie erhalten? Eine Subanalyse von #EASTAFNET4 liefert ein überraschendes Ergebnis ow.ly/Z4xx50KnN8B


Time to #AFFIRM recent trends of potential benefit with an early rhythm control strategy rather than rate control in #AtrialFibrillation with the #EASTAFNET4 trial? #cardiotwitter #ACCFIT nejm.org/doi/full/10.10…


📊 Exploratory analysis from #EASTAFNET4 via #EHJ: Early rhythm control for #AF, started within 30 days, reduced risk of stroke, worsening heart failure & cardiovascular death. Full study 👇 #AtrialFibrillation #RhythmControl #AFib

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

ehj_ed's tweet image. Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals


📊 Exploratory analysis from #EASTAFNET4 via #EHJ: Early rhythm control for #AF, started within 30 days, reduced risk of stroke, worsening heart failure & cardiovascular death. Full study 👇 #AtrialFibrillation #RhythmControl #AFib

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

ehj_ed's tweet image. Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals


Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

ehj_ed's tweet image. Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet 👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing? ✒️ @TJaredBunch et al 🔗doi.org/10.1111/jce.16…

JCardioEP's tweet image. 📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet

👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing?

✒️ @TJaredBunch et al

🔗doi.org/10.1111/jce.16…

Dass eine frühe rhythmuserhaltende Therapie bei #Vorhofflimmern klinisch von Vorteil ist, hat die #EASTAFNET4 Studie gezeigt. Dass diese Therapie wohl auch wirtschaftlich ist, legt eine Analyse ihrer Kosteneffektivität nahe. ow.ly/4qHy50NtM2z


En un análisis post-hoc del #EASTAFNET4 se observó disminución del riesgo de infarto cerebral 🧠 (primer evento / recurrencia). 🧵3/4


En el estudio #EASTAFNET4 se demostró que control de ritmo💃🏻 en pacientes con FA de diagnóstico reciente disminuye mortalidad 💀asociada a eventos cardiovasculares🫀. 🧵2/4


Welche #Vorhofflimmern Patienten sollten bevorzugt eine rhythmuserhaltende Therapie erhalten? Eine Subanalyse von #EASTAFNET4 liefert ein überraschendes Ergebnis ow.ly/Z4xx50KnN8B


✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR 🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure #CASTLEAF #Afib #EASTAFNET4#CNC2022 @HMethodistCV @LadorAdi

AayushShahMD's tweet image. ✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR

🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure  #CASTLEAF

#Afib     #EASTAFNET4#CNC2022            @HMethodistCV     @LadorAdi

Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu New guidelines per EAST-AFNET4: ✔️Statistically lower risk of stroke and mortality with early rhythm control ✔️Lower risk for hospitalization due to HF and ACS #Afib #EASTAFNET4 #CNC2022

AayushShahMD's tweet image. Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu

New guidelines per EAST-AFNET4: 
✔️Statistically lower risk of stroke and mortality with early rhythm control
✔️Lower risk for hospitalization due to HF and ACS

#Afib #EASTAFNET4 #CNC2022

#DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

Phiso_de's tweet image. #DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

#EHRA2022 🔥Late-Breaking Interview on a meta-analysis of EAST-AFNET 4 with @DrJasonAndrade 🫀Early rhythm control beneficial for #AF patients ⬇️ in cardiovascular outcomes Discover the key findings 🎥 ow.ly/Nvql50IIFal #EASTAFNET4 #AtrialFibrillation #EarlyRhythmControl


無症状AFに対するリズムコントロールの意義は? 少しずつエビデンス出てきましたね!嬉しいです。 #ESCCongress #EASTAFNET4 #U40HF

Rhythm control for all? Prespecified subanalysis of the EAST-AFNET 4 trial shows that early, systematic rhythm control was not different between asymptomatic and symptomatic patients academic.oup.com/eurheartj/arti… #EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes

ESC_Journals's tweet image. Rhythm control for all? Prespecified subanalysis of the EAST-AFNET 4 trial shows that early, systematic rhythm control was not different between asymptomatic and symptomatic patients academic.oup.com/eurheartj/arti… 

 #EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes


#EASTAFNET4 gilt als eine der wichtigsten Arrhythmie-Studien der jüngsten Zeit. Warum und wie ihre Ergebnisse die Praxis der Therapie bei #Vorhofflimmern grundlegend verändern könnten, war Thema bei der #DGKJahrestagung 2021 ow.ly/ARP150EpsRe


Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies More:bit.ly/34OfrUk @ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

CVR_TomaszGuzik's tweet image. Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies
More:bit.ly/34OfrUk
@ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

KnowYourPulse's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

AtrialFibUK's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

#EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

MDedgeCardio's tweet image. #EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

#EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

MDEdgeTweets's tweet image. #EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

Time to #AFFIRM recent trends of potential benefit with an early rhythm control strategy rather than rate control in #AtrialFibrillation with the #EASTAFNET4 trial? #cardiotwitter #ACCFIT nejm.org/doi/full/10.10…


No results for "#eastafnet4"

#DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

Phiso_de's tweet image. #DGKJahrestagung across the ocean! Live from New York City @VivekReddyMD on the most important EP studies like #EASTAFNet4 …. @AGEP_DGK @DGK_org @YoungDgk

📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet 👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing? ✒️ @TJaredBunch et al 🔗doi.org/10.1111/jce.16…

JCardioEP's tweet image. 📜 Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet

👓 #CABANA & #EASTAFNet4 (@afnet_ev ): ⬇️ mortality with ablation/rhythm control. Can mortality be ⬇️⬇️w improved ablation timing?

✒️ @TJaredBunch et al

🔗doi.org/10.1111/jce.16…

✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR 🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure #CASTLEAF #Afib #EASTAFNET4#CNC2022 @HMethodistCV @LadorAdi

AayushShahMD's tweet image. ✨Don’t forget the CHA2DS2VASc and HAS-BLED score to guide anti-coagulation treatment despite achieving NSR

🔥Catheter Ablation still preferred over AAD in patients with AF and heart failure  #CASTLEAF

#Afib     #EASTAFNET4#CNC2022            @HMethodistCV     @LadorAdi

Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies More:bit.ly/34OfrUk @ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

CVR_TomaszGuzik's tweet image. Atrial #fibrillation is not an innocent bystander. Prof Andreas Goette discusses the outcomes & pathophysiological consequences of the #EASTAFNET4 trial and lessons for future therapies
More:bit.ly/34OfrUk
@ESC_Journals @escardio #afib #AF #stroke #CardiovascularResearch

Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu New guidelines per EAST-AFNET4: ✔️Statistically lower risk of stroke and mortality with early rhythm control ✔️Lower risk for hospitalization due to HF and ACS #Afib #EASTAFNET4 #CNC2022

AayushShahMD's tweet image. Amazing teaching points regarding early rhythm control by @LadorAdi! @debakeycvedu

New guidelines per EAST-AFNET4: 
✔️Statistically lower risk of stroke and mortality with early rhythm control
✔️Lower risk for hospitalization due to HF and ACS

#Afib #EASTAFNET4 #CNC2022

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

ehj_ed's tweet image. Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial. Read this post-hoc analysis in the @EHJ at doi.org/10.1093/eurhea… #EASTAFNET4 #AtrialFibrillation #RhythmControl @ESCardio @ESC_journals

#EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

MDEdgeTweets's tweet image. #EASTAFNET4 study results: Early rhythm control in #AFib gains new life ms.spr.ly/6016TS7GM #ESCCongress

The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

KnowYourPulse's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar , outlines the key findings of these studies. bit.ly/ESC2020AFreport

#EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

MDedgeCardio's tweet image. #EASTAFNET4 trial results: Early rhythm control in #AFib gains new life ms.spr.ly/6019TtGnx #ESCCongress

The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

AtrialFibUK's tweet image. The virtual #ESCCongress saw several atrial fibrillation (AF) studies presented, including the much-discussed #EASTAFNET4 trial. This report, with comments from @ShouvikHaldar ,outlines the key findings of these studies. bit.ly/ESC2020AFreport

Loading...

Something went wrong.


Something went wrong.


United States Trends